Literature DB >> 30444130

Contextual compatibility of three empirically supported behavior therapies for cART adherence among patients with substance use disorders.

Bryan Hartzler1, Julia C Dombrowski2, Dennis M Donovan1,3.   

Abstract

Though substance use disorders complicate adherence to combination antiretroviral therapy (cART), cognitive-behavioral therapy (CBT), contingency management (CM), and motivational interviewing (MI) each demonstrate efficacy to improve cART adherence among substance-using patients. To inform dissemination of these therapies, this mixed-method study was undertaken involving a full-day site visit to each of four HIV care settings. At each setting, an initial administrator interview elicited setting data. Paired focus groups with setting staff and patients then served as forums for open discussion and live polling of the therapies' respective contextual compatibility. Focus group recordings were subjected to a phenomenological narrative analysis by multidisciplinary investigators, and staff/patient compatibility ratings were analyzed via generalized linear models. Findings include: (1) emergent themes among staff of adaptability, patient-centeredness, and mission-congruence as desired therapy attributes, (2) emergent themes among patients of intrinsic motivation, respect for patient autonomy in illness management, and fairness among service recipients as desired therapy attributes; and (3) comparatively stronger staff perception of compatibility for MI than CBT or CM, and a similar albeit less robust or reliable pattern among patients. Collective findings support MI as a behavior therapy of choice for broad dissemination to HIV care settings to improve cART adherence of patients with substance use disorders.

Entities:  

Keywords:  HIV/AIDS; Substance use disorders; behavior therapy; cART adherence

Mesh:

Substances:

Year:  2018        PMID: 30444130      PMCID: PMC6268161          DOI: 10.1080/09540121.2018.1545985

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  16 in total

1.  Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.

Authors:  Evan Wood; Robert S Hogg; Benita Yip; Winnie W Y Dong; Brian Wynhoven; Theresa Mo; Chanson J Brumme; Julio S G Montaner; P Richard Harrigan
Journal:  AIDS       Date:  2005-07-22       Impact factor: 4.177

2.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

3.  Sustaining motivational interviewing: a meta-analysis of training studies.

Authors:  Craig S Schwalbe; Hans Y Oh; Allen Zweben
Journal:  Addiction       Date:  2014-05-29       Impact factor: 6.526

4.  Sample size in qualitative research.

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  1995-04       Impact factor: 2.228

Review 5.  A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs.

Authors:  Meredith Camp Binford; Shoshana Y Kahana; Frederick L Altice
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

6.  Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.

Authors:  Enola Proctor; Hiie Silmere; Ramesh Raghavan; Peter Hovmand; Greg Aarons; Alicia Bunger; Richard Griffey; Melissa Hensley
Journal:  Adm Policy Ment Health       Date:  2011-03

7.  Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

Authors:  Evan Wood; Robert S Hogg; Viviane Dias Lima; Thomas Kerr; Benita Yip; Brandon D L Marshall; Julio S G Montaner
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

8.  The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Authors:  Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

9.  Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.

Authors:  Perrine Roux; M Patrizia Carrieri; Julien Cohen; Isabelle Ravaux; Isabelle Poizot-Martin; Pierre Dellamonica; Bruno Spire
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

10.  The unrealized potential of addiction science in curbing the HIV epidemic.

Authors:  Nora D Volkow; Ruben D Baler; Jacques L Normand
Journal:  Curr HIV Res       Date:  2011-09       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.